NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

COVID-19對美國的選擇性手術的影響:2020∼2023年

Impact of COVID-19 on Elective Procedures in the US, 2020-2023

出版商 Frost & Sullivan 商品編碼 981762
出版日期 內容資訊 英文 91 Pages
商品交期: 最快1-2個工作天內
價格
COVID-19對美國的選擇性手術的影響:2020∼2023年 Impact of COVID-19 on Elective Procedures in the US, 2020-2023
出版日期: 2020年12月11日內容資訊: 英文 91 Pages
簡介

由於COVID-19相關的措施造成的選擇性手術的延期,影響心血管醫療設備市場。儘管有些心血管手術很緊急,不過,其他手術重新安排而延期。COVID-19發生以後美國進行的整形外科手術整體約83.5%,為選擇性非不必須,而延遲、延期、取消。外傷,截肢,及腫瘤手術,是最重要的手術。髖關節,骨盆,前臂 的脫臼和骨折,僅在緊急情況下才考慮治療。

本報告提供在美國,COVID-19對選擇性外科手術/待命的外科手術的影響的相關調查,各市場區隔的需求預測的保守性情況和積極性情況,成長機會的分析。

目錄

COVID-19的影響

  • 分析的範圍
  • COVID-19對選擇性手術的影響
  • COVID-19對醫療保健產業的影響
  • COVID-19對手術數量趨勢的影響
  • COVID-19對CRM的影響
  • COVID-19對整形外科手術的影響
  • COVID-19對一般外科的影響
  • COVID-19對MedTech產業的影響

成長環境

  • 主要的預測標準

CRM

  • 情況1:保守性預測
  • 情況1:保守性收益預測
  • 情況1:保守性預測的討論
  • 情況2:積極性預測
  • 情況2:積極性收益預測
  • 情況2:積極性預測的討論

PCI

結構的心臟疾病市場

關節置換術

脊椎設備

RAS設備

RASD服務

其他的預測趨勢

  • 其他的預測趨勢
  • 醫療設備的未來展望

成長機會

  • 市場機會1:實現更迅速機敏的醫療保健的解決方案的計劃和調度
  • 市場機會2:精密手術的訓練
  • 市場機會3:醫療現場的助手醫療機器人

CTA

附錄:Growth Pipeline Engine

  • 關於 Growth Pipeline Engine
  • 接下來的步驟
  • 圖表清單
  • 免責聲明
目錄
Product Code: MF73-54

Growth Strategies to Navigate the Uncertainty Surrounding Elective Procedure Deferrals and their Impact on the Medical Device Market

The study offers an overview of the impact of COVID-19 on select medical devices. The deferral of elective procedures due to COVID-19-related measures has affected the cardiovascular medical device market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred. Nearly 83.5% of all orthopedic procedures performed in the United States have been delayed, postponed, or canceled since the COVID-19 outbreak, as they are considered to be elective and non-essential. Traumas, amputations, and oncological procedures are the top essential procedures. Dislocations and fractures, including hip, pelvis, and forearms, are considered for treatment only in urgent cases.

The top 10 procedures account for 62.5% percent of the total volume and include knee, hip, and shoulder replacements and spinal fusion procedures. These surgeries are being delayed to prevent the spread of COVID-19 and spare the use of beds, ventilators, and equipment. Guidelines that are being modified to allow the resumption of clinical activities and reopening of facilities for elective surgery in multiple phases will have a direct effect on the short-term demand for select medical devices. Although many hospitals and health systems have quickly set up telehealth services to address non-urgent medical issues, the reality is that not everything can be addressed by telehealth. Ecosystem participants have to actively plan their product pipeline and use innovative strategies to recoup the major disruption in 2020. By ensuring timely cleaning services and measures to observe social distancing, healthcare centers can make sure that patients feel safe when they come in to seek healthcare services. The study considers a conservative scenario and an aspirational scenario for demand projection until 2025.

Table of Contents

Impact of COVID-19

  • Scope of Analysis
  • Scope of Analysis (Continued)
  • Impact of COVID-19 on Elective Procedures
  • Impact of COVID-19 on Elective Procedures (continued)
  • Impact of COVID-19 on the Healthcare Industry
  • Impact of COVID-19 on Surgical Caseload Trends
  • Impact of COVID-19 on CRM
  • Impact of COVID-19 on CRM (continued)
  • Impact of COVID-19 on CRM (continued)
  • Impact of COVID-19 on Orthopedic Surgery
  • Impact of COVID-19 on General Surgery
  • Impact of COVID-19 on General Surgery (continued)
  • Impact of COVID-19 on General Surgery (continued)
  • Impact of COVID-19 on the MedTech Industry

Growth Environment

  • Key Forecast Criteria

CRM

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 1: Conservative Forecast Discussion
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Scenario 2: Aspirational Forecast Discussion

PCI

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 1: Conservative Forecast Discussion
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Scenario 2: Aspirational Forecast Discussion

Structural Heart Market

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 1: Conservative Forecast Discussion
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Scenario 2: Aspirational Forecast Discussion

Joint Replacement

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Scenario 1: Conservative Forecast Discussion
  • Scenario 2: Aspirational Forecast Discussion

Spinal Devices

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Forecast Discussion

RAS Devices

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Forecast Discussion

RASD Services

  • Scenario 1: Conservative Forecast
  • Scenario 1: Conservative Revenue Forecast
  • Scenario 2: Aspirational Forecast
  • Scenario 2: Aspirational Revenue Forecast
  • Forecast Discussion

Other Forecast Trends

  • Other Forecast Trends
  • Other Forecast Trends (Continued)
  • Medical Device Future Outlook

Growth Opportunities

  • Opportunity 1: Planning & Scheduling Solutions to Enable Faster and Agile Healthcare
  • Planning & Scheduling Solutions to Enable Faster and Agile Healthcare
  • Opportunity 2: Training for Precision Surgery
  • Training for Precision Surgery
  • Opportunity 3: Medical Robots as Assist in Healthcare Settings
  • Medical Robots as Assist in Healthcare Settings

Companies to Action

  • Companies to Action
  • Companies to Action (continued)

Appendix: Growth Pipeline Engine™

  • About the Growth Pipeline Engine™
  • Next Steps
  • List of Exhibits
  • List of Exhibits (continued)
  • Legal Disclaimer